HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beilei Wang Selected Research

neo-gambogic acid

1/2021Oral Delivery of Gambogenic Acid by Functional Polydopamine Nanoparticles for Targeted Tumor Therapy.
9/2020In vitro/in vivo evaluation of pH-sensitive Gambogenic acid loaded Zein nanoparticles with polydopamine coating.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beilei Wang Research Topics

Disease

22Neoplasms (Cancer)
12/2021 - 01/2014
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2020 - 03/2016
4Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
11/2019 - 01/2016
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2020 - 12/2015
2Wounds and Injuries (Trauma)
06/2022 - 12/2015
2Necrosis
06/2022 - 12/2015
2Rheumatoid Arthritis
12/2021 - 01/2017
2Neoplasm Metastasis (Metastasis)
12/2021 - 11/2020
2Liver Diseases (Liver Disease)
08/2021 - 06/2019
2Hepatocellular Carcinoma (Hepatoma)
11/2020 - 03/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2017 - 10/2016
2Alzheimer Disease (Alzheimer's Disease)
01/2012 - 01/2011
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2022
1Myocardial Infarction
01/2022
1Tertiary Lymphoid Structures
12/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Carcinogenesis
11/2020
1Hemolysis
09/2020
1Urinary Bladder Neoplasms (Bladder Cancer)
05/2020
1Cardiotoxicity
04/2020
1Malaria
02/2020
1Long QT Syndrome
01/2020
1Infections
01/2020
1COVID-19
01/2020
1Cardiac Arrhythmias (Arrythmia)
01/2019
1Bites and Stings (Sting)
01/2019
1Heart Diseases (Heart Disease)
01/2019
1Heart Failure
01/2019

Drug/Important Bio-Agent (IBA)

16Phosphotransferases (Kinase)IBA
12/2020 - 12/2015
11Pharmaceutical PreparationsIBA
08/2021 - 01/2016
3Antineoplastic Agents (Antineoplastics)IBA
04/2021 - 01/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022 - 10/2020
2neo-gambogic acidIBA
01/2021 - 09/2020
2polydopamineIBA
01/2021 - 09/2020
2Peptides (Polypeptides)IBA
11/2020 - 03/2017
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2020 - 01/2017
2ZeinIBA
09/2020 - 04/2020
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2020 - 04/2020
2Proteins (Proteins, Gene)FDA Link
01/2019 - 10/2014
2cyanoginosin LR (microcystin LR)IBA
03/2017 - 10/2014
2ibrutinibIBA
10/2016 - 10/2015
2IsofluraneFDA LinkGeneric
01/2012 - 01/2011
1Hemolysin Proteins (Hemolysins)IBA
06/2022
1Adenosine Triphosphate (ATP)IBA
06/2022
1Long Noncoding RNAIBA
01/2022
1bulleyaconitine AIBA
12/2021
1HydrogelsIBA
12/2021
1VaccinesIBA
12/2021
1Immune Checkpoint InhibitorsIBA
12/2021
1Cancer VaccinesIBA
12/2021
1Enhancer of Zeste Homolog 2 ProteinIBA
10/2021
1protoporphyrin IXIBA
09/2021
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
09/2021
1Prostaglandins AIBA
09/2021
1MicellesIBA
09/2021
1Nanoparticle Drug Delivery SystemIBA
04/2021
1Liposomes (Liposome)IBA
04/2021
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2021
1AlginatesIBA
01/2021
1RNA (Ribonucleic Acid)IBA
11/2020
1Biomarkers (Surrogate Marker)IBA
11/2020
1Ribosomal Protein S6IBA
11/2020
1Oxygen (Dioxygen)IBA
10/2020
1Photosensitizing Agents (Photosensitizers)IBA
10/2020
1Cyclin-Dependent Kinase 9IBA
10/2020
11-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2020
1SolventsIBA
09/2020
1Bulk DrugsIBA
09/2020
1Silicon Dioxide (Silica)FDA LinkGeneric
05/2020
1Poly(amidoamine)IBA
05/2020
1Dendrimers (Dendrons)IBA
05/2020
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2020
1Angiogenesis InhibitorsIBA
03/2020
1Ether (Diethyl Ether)IBA
01/2020
1EmetineIBA
01/2020
1Antiviral Agents (Antivirals)IBA
01/2020
1Potassium Channels (Potassium Channel)IBA
01/2020
1CHMFL-KIT-64IBA
11/2019
1ResveratrolIBA
06/2019
1PolyphenolsIBA
06/2019
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2019
1Imatinib Mesylate (Gleevec)FDA Link
01/2019
1Cysteine (L-Cysteine)FDA Link
01/2019
1Ion Channels (Ion Channel)IBA
01/2019
1NeurotoxinsIBA
01/2019
1Peptide Hydrolases (Proteases)FDA Link
01/2019
1Phospholipases (Phospholipase)IBA
01/2019
1Protease Inhibitors (Protease Inhibitor)IBA
01/2019
1VenomsIBA
01/2019
1LectinsIBA
01/2019
1fms-Like Tyrosine Kinase 3IBA
01/2019
1(E)- N- (4- ((4- methylpiperazin- 1- yl)methyl)- 3- (trifluoromethyl)phenyl)- 3- ((3- (2- (pyridin- 2- yl)vinyl)- 1H- indazol- 6- yl)thio)propanamideIBA
12/2018
1RNA Polymerase II (RNA Polymerase B)IBA
10/2018

Therapy/Procedure

9Therapeutics
04/2021 - 01/2020
3Oral Administration
10/2021 - 07/2016
1Injections
12/2021
1Immunotherapy
12/2021
1Photochemotherapy (Photodynamic Therapy)
10/2020
1Drug Therapy (Chemotherapy)
05/2020